key: cord-0948294-ck5elesp authors: Kurtaiş Aytür, Yeşim; Füsun Köseoglu, Belma; Özyemişci Taşkıran, Özden; Kutay Ordu Gökkaya, Nilüfer; Ünsal Delialioğlu, Sibel; Sonel Tur, Birkan; Sarıkaya, Selda; Şirzai, Hülya; Tekdemir Tiftik, Tülay; Alemdaroglu, Ebru; Figen Ayhan, Fikriye; Duyur Çakıt, Burcu; Genç, Aysun; Gündoğdu, İbrahim; Güzel, Rengin; Demirbağ Kabayel, Derya; Bilir Kaya, Başak; Öken, Öznur; Özdemir, Hande; Soyupek, Feray; Tıkız, Canan title: Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): The revised guideline for the acute, subacute, and post-COVID-19 rehabilitation date: 2021-05-25 journal: Turk J Phys Med Rehabil DOI: 10.5606/tftrd.2021.8821 sha: bf301c39a1adf86c33ba1f0c27037ee6d0719fba doc_id: 948294 cord_uid: ck5elesp Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psychological, and generalized systemic dysfunction. The severity of disease ranges from an asymptomatic infection or mild illness to mild or severe pneumonia with respiratory failure and/or death. COVID-19 dramatically affects the pulmonary system. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and has been developed in the light of the guidelines on the diagnosis and treatment of COVID-19 provided by the World Health Organization and Republic of Turkey, Ministry of Health, recently published scientific literature, and PR recommendations for COVID-19 regarding basic principles of PR. This national guideline provides suggestions regarding the PR methods during the clinical stages of COVID-19 and post-COVID-19 with its possible benefits, contraindications, and disadvantages. Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. [1] The first case in Turkey was identified on March 11 th , 2020. [2] The World Health Organization (WHO) declared COVID-19 as a pandemic on March 12 th , 2020. [3] SARS-CoV-2 is a beta-coronavirus with a genetic sequence highly similar to SARS virus. [3] Angiotensinconverting enzyme 2 (ACE-2) found in the lower respiratory airways of humans is a cellular receptor for SARS-CoV and has been shown to play a role in the spread from one human being to another and in crosstransmission. [4, 5] The ACE-2 is mainly associated with cardiovascular diseases and it is a type I membrane protein expressed by the lungs, heart, kidneys, and bowel. [6] While most individuals with COVID-19 develop only mild (40%) or moderate (40%) disease, approximately 15% develop severe disease which requires oxygen support, and 5% have critical disease with complications such as respiratory failure, acute respiratory distress syndrome (ARDS), sepsis and septic shock, thromboembolism, and/or multi-organ failure, including acute kidney injury and cardiac injury (Tables 1, 2). [3] Elderly individuals and individuals with underlying health conditions (diabetes, hypertension, cardiac disease, chronic lung, kidney and hepatic disease, obesity and cancer) are more prone to infection and more inclined to ARDS and severe consequences that may be related to cytokine storms. [7, 8] Among hospitalized COVID-19 patients, approximately 33% develop ARDS, 26% require transfer to an intensive care unit (ICU), 16% receive invasive mechanical ventilation (IMV), and 16% die. [9] As in cases of ARDS due to other causes, age and comorbid disease states are reported as risk factors for COVID-19, as well. In multivariate analysis, advanced age, a high Sequential Organ Failure Assessment (SOFA) score, and an elevated D-dimer level at the time of admission were associated with higher mortality. [3] In COVID-19, the mortality rate was reported as 40% in patients admitted to ICU, 59% of those who received IMV, and 45% in COVID-19-associated ARDS. [9] Autopsies were performed in 10 African American decedents aged 44 to 78 years with a cause of death attributed to COVID-19. Important findings included the presence of thrombosis and microangiopathy in the small vessels and capillaries of the lungs, with associated hemorrhage, that significantly contributed to death. Pathological features of diffuse alveolar damage including hyaline membranes were reported even in patients who had not been on IMV. There were also cardiac findings, such as individual cell necrosis without lymphocytic myocarditis. [10] The long-term sequelae of COVID-19 are still unknown. Lessons from past viral epidemics reveal that, after recovery, patients with viral pulmonary infections can suffer from irreversible pulmonary dysfunction and demonstrate residual imaging or functional abnormalities. Residual ground-glass opacities, consolidations, reticular and linear opacities, Symptoms and risk factors associated with COVID-19 [3] residual crazy paving pattern, melted sugar sign, and parenchymal fibrotic bands are typical features found in the late or remission stages of COVID-19. These radiological findings can be observed weeks after the symptom onset, even after hospital discharge, and they may or may not correlate with clinical manifestations. [11] Currently, there is no specific antiviral drug for COVID-19. Although there is no approved antiviral regimen, drugs including lopinavir/ritonavir, remdesivir, favipiravir, umifenovir, emtricitabine, chloroquine and hydroxychloroquine, azithromycin, immunomodulators (i.e., tocilizumab, anakinra, interferon-β-1a), and plasma therapy are being used. [3] As of March 2021, there are more than 300 vaccine candidates at different development stages. [12] An efficacious vaccine is essential to prevent further morbidity and mortality. Several technological methods (e.g., DNA, RNA, inactivated, viral vector, protein subunit) are available for vaccine development. [13] Vaccination has started in many countries worldwide with several different vaccines. The guidelines by the Republic of Turkey, Ministry of Health define the patients complying with the diagnoses of pneumonia and severe pneumonia and the indications for admission to ICU for our country in detail. [14] As there is no adequate data about the longterm results, the degree of damage or sequela after the active disease is not known. Being the main target, respiratory system seems to be one of the most vulnerable systems for the unforeseen damage or sequela. This situation requires a good planning of post-COVID-19 management in the long-term setting, including pulmonary rehabilitation (PR). In a patient-specific manner, PR is planned based on a detailed patient assessment including but not limited to training, exercise, and behavioral [3] Mild disease Symptomatic patients meeting the case definition for COVID-19 without evidence of viral pneumonia or hypoxia. Moderate disease Pneumonia [73] Adolescent or adult with clinical signs of pneumonia (fever, cough, dyspnea, fast breathing) but no signs of severe pneumonia, including SpO 2 ≥90% on room air. Severe disease Severe pneumonia [73] Adolescent or adult with clinical signs of pneumonia (fever, cough, dyspnea, fast breathing) plus one of the following: respiratory rate >30 breaths/min; severe respiratory distress; or SpO 2 <90% on room air. Critical disease Acute respiratory distress syndrome (ARDS) [74] [75] [76] Onset: Within one week of a known clinical insult (i.e. pneumonia) or new or worsening respiratory symptoms. Critical disease Sepsis [77, 78] Adults: Acute life-threatening organ dysfunction caused by a dysregulated host response to suspected or proven infection. Signs of organ dysfunction include: altered mental status, difficult or fast breathing, low oxygen saturation, reduced urine output, fast heart rate, weak pulse, cold extremities or low blood pressure, skin mottling, laboratory evidence of coagulopathy, thrombocytopenia, acidosis, high lactate, or hyperbilirubinemia. Septic shock [77, 78] Adults: Persistent hypotension despite volume resuscitation, requiring vasopressors to maintain MAP ≥65 mmHg and serum lactate level >2 mmol/L. See the WHO website for most up-to-date case definitions. [79] SpO2: Pulse oxygen saturation; CT: Computed tomography; PaO2: Partial pressure arterial oxygen; FiO2: Fraction of inspired oxygen; PEEP: Positive end-expiratory pressure; CPAP: Continuous positive airway pressure; MAP: Mean arterial pressure; a : If altitude is higher than 1000 m, then the correction factor should be calculated as follows: PaO2/ FiO2 ¥ barometric pressure/760; b : When PaO2 is not available, SpO2/FiO2 ≤315 suggests ARDS (including in non-ventilated patients). changes, since it aims at improving the physical and psychological status of individuals with chronic respiratory disease and focuses on comprehensive interventions for long-term commitment to health improvement attitudes. [15] Although PR has classically been defined for the treatment of chronic pulmonary diseases, it is also needed and implemented during the course of different pulmonary diseases and during immobility, surgery, and systemic, neurological, and musculoskeletal diseases which impair breathing. Pulmonary rehabilitation procedures will definitely be necessary for the right patient at the right time. [16] [17] [18] In patients with COVID-19 pneumonia or ARDS, multidisciplinary and holistic approach in COVID-19 management encompasses the PR with the selection of appropriate components according to the individual needs. Although indications of PR specific to COVID-19 are not clear, general indications can be listed as follows, when the effects of the disease on the respiratory system and its consequences are taken into consideration: Table 3 . The most important routes of transmission for COVID-19 between humans are close contact and droplet spread. Therefore, healthcare workers (HCWs) who provide service to these patients are regarded as having a high risk of transmission and the protection of HCWs is one of the most important priorities. There are guidelines issued by both WHO [3, 19] and the Republic of Turkey Ministry of Health [20] concerning the use of personal protective equipment (PPE). According to these guidelines, HCWs having contact with possible/ confirmed COVID-19 patients have to use PPE appropriate for droplet, contact, and aerosolization type routes of transmission. For all the patients diagnosed with COVID-19, HCWs need to use surgical masks, gowns, gloves, goggles/shields during patient care/treatment. During procedures with the potential of aerosol transmission of the virus (respiratory tract sampling, close distance examinations, all types of invasive procedures, respiratory secretion aspirations, etc.) HCWs should definitely use particle-blocking masks (N95). In the guideline issued by the Republic of Turkey Ministry of Health, risk stratification has not been made for PR bronchial drainage techniques such as assisted coughing techniques, respiratory exercises, postural drainage and percussion. However, some of the published guidelines state that all these procedures will lead to aerosol production and that the HCW should definitely use an N95 mask. [21, 22] The HCWs should also respect the sequencing rules when donning/doffing of PPE. This national guideline was prepared to inform primarily the physical medicine and rehabilitation (PMR) specialists and other physicians who follow COVID-19 patients. This guideline provides suggestions regarding the PR methods during the clinical stages of COVID-19 and post-COVID-19 with its possible benefits, contraindications and disadvantages. This guideline is prepared in the light of COVID-19 diagnosis and treatment guidelines of WHO and the Republic of Turkey, Ministry of Health, Public Health General Directorate, [3, 18] of published articles on COVID-19 treatment and published expert opinion recommendations on PR for COVID-19. It contains recommendations for adult patients. The guideline includes PR recommendations for different clinical presentations of COVID-19 and prolonged symptoms and impairments after COVID-19 to help patients recover the disease. At the time of establishment of these recommendations, the transmissibility of COVID-19, the principle of a limited number of HCWs having contact with the patient and the level of benefits to be provided by PR were taken into account. For the purpose of developing a PR guideline to be used in the treatment of COVID-19 patients, PMR specialists who are experienced in the field of Specialists drafted the guideline on behalf of these two associations. [24] Finally, the new version including PR recommendations for post-COVID-19 was developed. The steps listed below were followed in the preparation of the guideline: 1. AGREE II framework was followed in the development of the guideline. [25] 2. The literature search was conducted on PubMed, CINAHL, Google Scholar, Cochrane and related online databases. In the literature review, guidelines and recommendations during the last decade, meta-analyses, systematic reviews, randomized studies, and websites of relevant agencies such as WHO and the Republic of Turkey, Ministry of Health were analyzed. The language of the literature search was English. Furthermore, references translated into Turkish were used. Keywords were identified as "Coronavirus pneumonia", "Rehabilitation AND Coronavirus infection", "COVID-19", "SARS-CoV-2", "ARDS", "SARS", "MERS", "Influenza pneumonia", "Pulmonary rehabilitation AND Pneumonia", "Pulmonary rehabilitation after COVID-19", "Respiratory rehabilitation AND respiratory failure", "Rehabilitation AND Critically ill patient". 3. After all the participants reviewed the data obtained by this search, key research questions were prepared in accordance with the PICO framework. [26] The prepared questions were individually reviewed by five of the authors (FK, NKOG, SÜD, TT, YKA), similar questions were combined and the questions were arranged for a common language and for the sake of clarity. The questions were tailored according to the Delphi technique and the final version was approved unanimously by the five-member group. 4. One hundred and ninety questions were prepared and sent to all the participants with the Qualtrics Program to be reviewed by the Delphi technique. In the light of scientific publications and personal experience, the participants were asked to mark each question as "Yes", "No" or "Do not know/ Neutral". The questions receiving more than 70% of the common view were approved as research questions and those receiving less than 70% of consensus were re-evaluated by the participants. In the second round, the questions approved with a rate of 65% were accepted as research questions. The vast majority of the literature data on the definition of PR and the effectiveness of different methods on mortality and morbidity are based on experiences in chronic pulmonary disease and mainly chronic obstructive pulmonary disease (COPD). There is still no literature with high-quality evidence about the use of PR for acute respiratory failure/ ARDS, COVID-19 and similar acute infectious conditions. Therefore, while preparing a PR guideline for COVID-19, there was a need to consider the characteristics of this disease and its transmissibility together with the results of other methods whose efficacy were investigated for chronic diseases to prioritize condition appropriate and individualized recommendations. In the preparation of the recommendations for PR applications, the following topics were emphasized: • Clinical symptoms are mild at this clinical condition. It is important that these individuals stay home and achieve a balance between rest and physical activity by paying attention to their symptoms. At a time when it is compulsory for these individuals to stay at home, indoor exercises such as marching on spot, joint range of motion (ROM), posture, balance and coordination exercises in conformity with the existent physical activity guidelines and criteria to symptom limit such as fatigue, dyspnea, dizziness etc. are suggested to refrain from adverse effects of physical activity restriction. [27, 28] During the mild disease, preventive measures such as cessation of smoking, sleep hygiene, nutritional balance, adequate fluid intake, and supportive measures recommended by the health authorities and guidelines should be taken. [29] [30] [31] [32] [33] [34] Individuals with special conditions (i.e., older age, immunocompromised, neurological, pulmonary, cardiovascular, musculoskeletal, metabolic or other systemic diseases) can be evaluated by a PMR specialist and their rehabilitation program should be planned and revised accordingly, in case of a recent functional deterioration. It is recommended to apply an individualized pulmonary rehabilitation program for the patients diagnosed with COVID-19 pneumonia when deemed appropriate after assessment. When the first version of this guideline was published in Turkey, patients diagnosed with COVID-19 pneumonia with moderate disease were mostly hospitalized. However, as the knowledge accumulated about the nature and progress of the disease and the capacity with the variety of options of health services became clearer, hospitalization criteria changed. According to recent guidelines of the Republic of Turkey, Ministry of Health [35] [36, 37] For the patients followed at home: • It is recommended to apply same treatment guidelines and instructions mentioned above for the patients. Although there is no such infrastructure at the moment, the symptoms may be questioned via telemedicine (mostly phone calls, and home visits, when needed) and patients in the need of PR may be selected and further information may be supplied and supported with booklets, videos, social media applications or other available telerehabilitation methods. All patients, either in hospital or at home, should be recommended to perform ROM and mobilization activities to the limit of fatigue and other symptoms. Pulmonary rehabilitation program may include the utilization of devices for individual use such as incentive spirometry, flutter breathing devices, positive expiratory pressure (PEP) and having sputum expelled with controlled cough and huffing maneuvers and finally breathing strategies. As these activities result in aerosol formation, necessary measures should be taken to prevent spreads to the environment (i.e., collecting the sputum in closed plastic bags, patient wearing a mask while performing breathing strategies and cough maneuvers, in negative pressurized rooms). [38] Although aerobic exercises, respiratory and general muscle strengthening exercises were also recommended in some earlier guidelines, [36] [37] [38] [39] [40] [41] at the acute pneumonia stage, it is not recommended to routinely apply these exercises. [42, 43] Pulmonary rehabilitation to be used at this stage is thought to help to manage problems such as dyspnea, cough and sputum, anxiety and depression; [44] however, there are no such data in the context of evidence-based medicine for COVID-19. [36, 37, 41, 45] All patients who have prolonged immobility, frailty, multiple comorbidities such as stroke, spinal cord injury, cardiac or respiratory diseases, functional decline in daily activities should have rehabilitation interventions for breathing strategies, mobilization, and ROM exercises. These individuals should be evaluated by a PMR specialist and the patient's still ongoing home-based rehabilitation program should be revised or a new program should be recommended tailored to the needs of the patient, and various methods such as booklets or telemedicine can be used. The use of individual devices, mobilization techniques and exercises prescribed by the PMR specialist should be instructed to the patient by one of the rehabilitation team members. These practices can be performed by PMR specialist or existing healthcare personnel (nurse, physiotherapist, occupational therapist, physiotherapy technician, etc.) depending on the present conditions, and availability of human resources and PPE at the facility. [46] The frequency of PR interventions should be planned according to the patient's status. It is recommended to perform a regular follow-up of the rehabilitation program and revised accordingly considering the patient's clinical status. The PR programs can be offered by the use of printed and visual materials, videos, social media, telerehabilitation in the presence of eligible infrastructure. It is recommended to plan an individualized pulmonary rehabilitation program for patients with severe COVID-19 pneumonia and to start implementing the program after the patient becomes medically stable and fulfills the following criteria: • Initial diagnosis time or symptom onset ≥7 days; initial onset of dyspnea ≥3 to 5 days • Respiratory system [36, 37] -FiO 2 ≤0.6 -SpO 2 ≥90% on oxygen therapy -Respiratory rate ≤40 breaths/min -PEEP ≤10 cmH 2 O -Absence of ventilator resistance After the assessment of the general condition, fever, respiratory symptoms such as dyspnea, cough, respiratory rate, SpO 2 , blood tests, radiological findings, ROM, respiratory and peripheral muscle strength, functional capacity, exercise capacity and other comorbid disease states, a rehabilitation program appropriate for the current impairments of the patient should be planned. Many guidelines and expert recommendations suggest that PR should be applied to COVID-19 patients with severe pneumonia. Although it is thought that PR to be implemented during this period will help to manage symptoms such as dyspnea, cough, sputum, weaknesses of respiratory and peripheral muscles, immobilization, anxiety and depression; there is still no such data in the context of evidence-based medicine. The evidence obtained from studies evaluating the effectiveness of PR is mostly derived from research performed on individuals with chronic pulmonary diseases. [15, 35, 43, 47] Research related to rehabilitation in COVID-19 is still sparse. [48] Yet, the studies mainly focus on the clinical presentation of COVID-19 rather than the efficacy of rehabilitation intervention and their level of evidence is either category 3 or 4. [49] It is recommended to discontinue PR, if the following conditions occur: [18, 21, 22, 38, 41, 50, 51] • -For patients having sputum and productive cough, airway clearance techniques should be used. The patient should be taught how to expel the sputum that has accumulated and the central airways should be cleared by maneuvers such as controlled cough and huffing. Devices for personal use such as incentive spirometry, flutter breathing devices, and PEP may also be prescribed to mobilize sputum to central airways and maneuvers such as controlled cough and huffing should be repeated. -Controlled breathing techniques including diaphragmatic breathing, alternate breathing, and pursed-lip breathing may be used. However, it should be kept in mind that the use of these techniques may increase the respiratory workload during the acute stage and further lead to deterioration of the patient's condition. The use of individual devices, mobilization techniques and exercises prescribed by the PMR specialist should be instructed to the patient by one of the rehabilitation team members. These practices can be performed by PMR physician or existing healthcare personnel (nurse, physiotherapist, occupational therapist, physiotherapy technician, etc.) depending on the present conditions, and availability of human resources and PPE at the facility. [46] The frequency of PR interventions should be planned according to the patient's status. It is recommended to perform a regular follow-up of the rehabilitation program and revised accordingly considering the patient's clinical status. Rehabilitation interventions such as positioning, mobilization, ROM exercises can be performed by a team member. Training of PR interventions which require active participation of the patient (such as controlled breathing techniques, using of devices) should be provided by a team member, individually. PR programs may be offered by the use of printed and visual materials, videos, social media, telerehabilitation in the presence of eligible infrastructure. Comprehensive PR in COVID-19 during ARDS is not required, but rehabilitation principles to avoid adverse effects of immobilization and for secretion management should be followed. Pulmonary rehabilitation is not appropriate or safe for ARDS patients in respiratory stress whose PaO 2 /FiO 2 <300 mmHg (on ventilator settings or PEP/continuous positive airway pressure (CPAP) of >5 cmH 2 O), and mostly have fever (>38°C), respiratory rate of >40 breaths/min, oxygen saturation of <90% despite oxygen support, HR <40 or >120 beats/ min, or have variable arrhythmia, BP <90/60 or >180/90 mmHg, who are in shock, deep sedation and who has radiological progression more than 50% in the last 24-48 hours. [21, 22, 38, 41, 50, 51] -Pulmonary rehabilitation is not appropriate and safe in ARDS patients who are in prone position which is preferred to increase oxygenation for 12 to 16 hours. -During the following rehabilitation interventions, vital and respiratory stress signs should be closely monitored. -In patients requiring secretion management, these procedures should be done in negative pressure rooms and/or isolated rooms and closed systems, as this may cause aerosol formation. Mechanical insuff lator and exsufflator (MI-E) and oscillating devices, which are other airway cleaning techniques used in the intensive care, should be used very carefully considering the benefit/harm due to aerosol formation. -Patients should be carefully inspected for pressure ulcers. Attention should be paid to the proper positioning. -Range of motion exercises in 10-15 repetitions/ day for each joint should be performed when the patient is in the supine position. When the patients can participate, they can do active or assisted exercises. -Mobilization exercises and self-care activities can be started when the general condition and cooperation of the patient allows. -Electrical stimulation modalities such as NMES can be used in patients with muscle weakness for large muscle groups at an intensity that will not cause any burns. The patient who is recovering and/or in the weaning period should be evaluated together with the PMR physician and the ICU physicians about the eligibility and the timing of rehabilitation. If the patient fulfills the eligibility criteria for PR (Recommendation 3.1 and 3.2) the recommendations for COVID-19 patients with severe pneumonia should be followed. After the critical disease and ICU period, the patient who has functional limitations, such as difficulty in mobility or other activities of daily living, and persistent symptoms should be evaluated and a patient-specific rehabilitation program is planned by the PMR specialist. During the evaluation process, the general condition of the patient, the blood tests, radiological findings, respiratory parameters, joint ROM, muscle strength, respiratory muscle strength, activities of daily living, functional capacity and other existing comorbid conditions are considered. At this transition stage, respiratory muscle exercises (inspiratory muscle training, expiratory muscle training), breathing strategies (controlled breathing techniques, airway clearance techniques) and aerobic training, progressive resistive exercises and shoulder girdle and upper extremity exercises can be progressively recommended only if the patient's status allows. For PR, criteria outlined in above recommendations should be followed. Comprehensive PR is indicated for individuals with ongoing fatigue, respiratory symptoms, diminished activities of daily living, reduced exercise tolerance, and limited functionality 6 to 8 weeks following discharge. As of April 15 th , 2021, the number of individuals infected with SARS-CoV-2 virus over the world exceeded 136 million. At the beginning of the pandemic, COVID-19 was thought of as a disease that affects primarily the pulmonary system. Soon after, it has been understood that, it is a multisystem disease with complications affecting the cardiac, renal, gastrointestinal, nervous, endocrine and musculoskeletal systems. However, pulmonary involvement still remains significant. A more serious prognosis is expected in patients who have complications related to pulmonary involvement. In many studies, prolonged symptoms of fatigue, dyspnea and breathlessness are reported in patients besides symptoms related to other systems. [52] [53] [54] These complications, particularly pulmonary related problems, have the potential to impair the patient's quality of life by limiting their daily living activities, and reduce exercise capacity. Thus, all these reveal the need for comprehensive PR in patients after COVID-19. The current guidance for routine postexacerbation PR for COPD is 4 weeks post discharge; however, the recommendation to delay PR for COVID-19 patients until 6 to 8 weeks post-discharge was based upon the following considerations. First, there is a lack of data about the decay of the levels of infection in the COVID-19 survivor. Second, there is data suggesting that, a proportion of physical recovery will have occurred in ARDS survivals in two months. [55] Also, it may be a burden for services to recruit patients at an earlier time after discharge. [56] Hospitalized patient with COVID-19 including the survivors of acute respiratory failure should be evaluated at 6 to 8 weeks following hospital discharge. Multiple re-assessments may be required at different time points such as 3 and 6 months after discharge, and a PR program can be initiated according to the individual needs of the patient. Patients who exhibit signs of respiratory impairment whether accompanying musculoskeletal, swallowing, functional, cognitive or psychosocial problems exist or not are the main candidates for a comprehensive PR program. A detailed information on comprehensive PR program exists in the introduction section. Particular attention should be paid to the following criteria: Comprehensive PR should be applied in a wellappointed PR setting. After the assessment and program prescription by the PMR physician, an approach can be made with a core rehabilitation team consisting of PMR physician, nurse, physiotherapist and occupational therapist, as well as with a wider rehabilitation team including psychologist, nutritionist, speech and swallowing therapist, etc. according to the identified deficits and problems of the patient. Although the core rehabilitation team is mostly sufficient, individualized protocols with expanded, systematic and organized determinants are one of the most important steps of a successful PR. The PR setting for the post-COVID-19 patients should be chosen based on the clinical status, existing impairments and characteristics of the patients. Inpatient rehabilitation may be indicated in patients with tracheostomy, CPAP or bilevel positive airway pressure (BIPAP) therapy, requiring high levels of oxygen therapy at rest, extra-pulmonary comorbidities or severe limitations in the activities of daily life. PR as an outpatient setting may be appropriate for the patients who are sufficient to handle their daily activities and without transportation limitations. A home setting may be used in clinically stable patients and who do not require monitorization by a health professional during sessions. The delivery of PR program may vary due to the PR setting and the ongoing risk of contagiousness such as the usual face-to-face intervention, visual tools including brochures, booklets, and telemedicine interventions. Since telerehabilitation is a novel approach for many healthcare facilities, special considerations should be taken into account for the implementation of PR via telerehabilitation. In patients who are appropriate for home-based PR, telerehabilitation could be used, when there is a need for social distancing, there are accessibility, transportation or cost issues, or there is no available PR program. For the implementation of telerehabilitation, there should be sufficient technological set-up both at the facility and the patient's home and adequate caregiver support if needed; the patient should be capable of understanding and following instructions via technological means, and vital parameters (SpO 2 , HR, BP, respiratory rate) and the symptoms should be recorded by the patient/ caregiver before the telerehabilitation session, and informed and monitored. The patients should be questioned to ensure that they do not have any symptoms of recurrent COVID-19 and any of the exclusion criteria for PR before the assessment and rehabilitation program. In case they have symptoms of COVID-19, they should be advised to self-isolate for 10 days or in line with the current guidance. If there are no symptoms indicating a new infection, patient can start the program. The contagiousness of COVID-19 is shown to be lasting up to 10 days usually and up to 30 days in some severe cases. Since the assessments and rehabilitation program are planned to be performed 6 to 8 weeks after the discharge, there is no need for swab testing unless recurrent/new infection is suspected. Currently, results of antibody testing should not change the program planning. All patients should be thoroughly assessed as recommended by the PR guidelines before the PR program, and multi-system examination using biopsychosocial approach should be performed considering the various impacts of COVID-19, as well. Assessments are done mainly on six domains: According to the severity of the disease and length of hospitalization, there may be symptoms and impairments other than those of the respiratory system. Therefore, each patient's further evaluation should be individual based on the existing impairments and symptoms and may include nutritional, cognitive, orofacial including swallowing and speech, systemic, particularly cardiac and neurological assessments. Vocational assessment and returning to work strategies should be also considered. During the assessments and rehabilitation program, guidelines should be followed regarding the prevention of spread of the disease such as social distancing, hygiene of the patient and the facility, even if the patient is considered to be noncontagious. All HCWs involving in the PR process of COVID-19 patients should wear appropriate PPE using proper techniques to avoid selfcontamination. Even if the patients considered to be non-contagious, eye protection, donning of gloves and disposable gown besides face masks should be used during aerosol-generating procedures. All patients should wear surgical masks during rehabilitation. If possible, exercise testing rooms should be equipped with negative pressure systems and HEPA filters. Otherwise, exercise testing rooms should be aerated well after each patient and there should be at least 30 min between two patients' tests and assessments. All surfaces should be sanitized after each patient's assessment and rehabilitation session. A unique set of principles should be implemented for the exercise areas, as well. The number of patients rehabilitated at the same time should be limited to allow social distancing and depends on the field's size. The waiting room and appointments should be arranged accordingly to ensure necessary social distancing. The number of COVID-19 cases in our country has been increasing, similar to the world. This guideline is prepared by taking the health practices in our country into consideration. It aims to provide guidance primarily to PMR specialists and to all physicians. PMR specialists taking part in the development of this guideline are experienced in PR and they rehabilitate COVID-19 patients in both acute and chronic stages in different hospitals across Turkey. Some have gained experiences in treating COVID-19 patients as their primary physicians, as well. This guideline will create an opportunity for sharing experiences in line with COVID-19 treatment guidelines. This guideline was prepared with the aim of incorporating the principles of PR with scientific data pertaining to the COVID-19 pandemic which has started nearly a year ago. Although the knowledge and experience about rehabilitation in acute COVID-19 have accumulated, scientific quality is not adequate for a strong level of evidence. Yet, research concerning rehabilitation outcomes on chronic COVID-19 symptoms in long term or outcomes of tele-rehabilitation are still scarce in number. Recommendations may need adaptations according to the condition of the patients, available resources and experience of the healthcare professionals. Following the publication of this second version of the guideline, we aim at revising it, if new evidence about the PR emerges and after evaluating the results of clinical applications and long-term results of the patients within a period of 6 to 12 months. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China World Health Organization. COVID-19 Clinical Management -Living Guidance -25 ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus A novel angiotensin-converting enzymerelated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 COVID-19 and comorbidities: Deleterious impact on infected patients Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Incidence of ARDS and outcomes in hospitalized patients with COVID-19: A global literature survey Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans The lingering manifestations of COVID-19 during and after convalescence: Update on long-term pulmonary consequences of coronavirus disease Vaccine Centre, London School of Hygiene and Tropical Medicine Developing Covid-19 vaccines at pandemic speed statement: Key concepts and advances in pulmonary rehabilitation Pulmonary rehabilitation. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Tru-cut needle pleural biopsy and cytology as the initial procedure in the evaluation of pleural effusion COVID-19 Rehberi Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages. Interim Guidance COVID-19 Pandemisinde Sağlık Kurumlarında Çalışma Rehberi ve Enfeksiyon Kontrol Önlemleri Respiratory physiotherapy in patients with COVID-19 infection in acute setting: A Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR) Physiotherapy management for COVID-19 in the acute hospital setting: Clinical practice recommendations Cardiopulmonary Rehabilitation Study Group of Turkish Society of Physical Medicine and Rehabilitation Specialists. COVID-19 Sonrası pulmoner rehabilitasyon. Istanbul: Turkish Society of Physical Medicine and Rehabilitation Specialists Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation Development of the AGREE II, part 1: Performance, usefulness and areas for improvement The well-built clinical question: A key to evidence-based decisions World Health Organization. Support for Rehabilitation Self-Management after COVID-19-Related Illness. Geneva: World Health Organization ACSM's Guidelines for Exercise Testing and Prescription Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients The relationship between dietary fiber intake and lung function in the national health and nutrition examination surveys Dietary antioxidants significantly attenuate hyperoxiainduced acute inflammatory lung injury by enhancing macrophage function via reducing the accumulation of airway HMGB1 Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial The effect of intravenous selenium on oxidative stress in critically ill patients with acute respiratory distress syndrome Zinc deficiency primes the lung for ventilator-induced injury Response to pulmonary rehabilitation: Toward personalised programmes? Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19 Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19) Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: The Italian position paper COVID-19: Interim guidance on rehabilitation in the hospital and post BTS Guidance for pulmonary rehabilitation -Reopening services for the 'business as usual' participants Chinese Association of Rehabilitation Medicine; Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019 Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient British Thoracic Society guideline on pulmonary rehabilitation in adults Effectiveness of controlled breathing techniques on anxiety and depression in hospitalized patients with COPD: A randomized clinical trial Rehabilitation needs of the first cohort of post-acute COVID-19 patients in Hubei, China Hemşirelik Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult Physical rehabilitation in intensive care unit in acute respiratory distress syndrome patients with COVID-19 International Multiprofessional Steering Committee of Cochrane Rehabilitation REH-COVER action. Rehabilitation and COVID-19: A rapid living systematic review 2020 by Cochrane Rehabilitation Field. Update as of Handbook of COVID-19 prevention and treatment. The First Affiliated Hospital Zhejiang University School of Medicine compiled according to clinical experience. 2020. E-book Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19 Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation Physical function trajectories in survivors of acute respiratory failure Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Referrals, uptake and adherence Pulmonary rehabilitation mona r y-rehabi l it at ion?sea rch=pu l mona r y %20 rehabilitation&source=search_ result&selectedTitle=1~97 &usage_ type=default&display_rank=1 Medical Research Council-sumscore: A tool for evaluating muscle weakness in patients with post-intensive care syndrome Chelsea physical assessment tool for evaluating functioning in post-intensive care unit COVID-19 patients Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical characteristics of coronavirus disease 2019 in China Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: A cross-sectional study The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility Epidemiology of Covid-19 in a longterm care facility in King County Atypical presentation of COVID-19 in a frail older person A systematic scoping review of COVID-19 during pregnancy and childbirth CDC COVID-19 Response Team. Coronavirus disease 2019 in children -United States World Health Organization. IMAI District Clinician Manual: Hospital Care for Adolescents and Adults. In: Guidelines for the management of common illnesses with limited resources Switzerland: World Health Organization Acute respiratory distress syndrome: The Berlin Definition Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: Definition, incidence, and epidemiology: Proceedings from the Pediatric Acute Lung Injury Consensus Conference Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali Modification of the Berlin Definition Surviving sepsis campaign: International guidelines for management of sepsis and septic shock Surviving sepsis campaign international guidelines for the management of septic shock and sepsisassociated organ dysfunction in children World Health Organization. Country & technical guidance -coronavirus disease (COVID-19). Geneva: World Health Organization We would like to thank to the PMR specialists who participated in the Delphi round for the development of The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. The authors received no financial support for the research and/or authorship of this article.